Appropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems.

作者: F. Colardyn

DOI: 10.1179/ACB.2005.011

关键词:

摘要: Treatment of serious nosocomial infections in the intensive care unit requires swift, effective, well-tolerated and appropriate therapy from outset. The consequences inappropriate treatment, i.e. use antibiotics that are ineffective against causative pathogen(s) or delayed therapy, numerous impact negatively upon both patient ever-dwindling healthcare resources many hospitals. Although have revolutionised treatment infections, their untimely within setting has led to emergence spread antibiotic-resistant bacteria worldwide. Consequently, ensure successful outcomes (reduce morbidity mortality), it is important any antibiotic employed right first time. an empirical stratagem providing broad-spectrum coverage a wide range suspected difficult-to-treat pathogens such as Pseudomonas aeruginosa. However, prevent errors past, this needs be tailored soon pathogen been identified resistance patterns known. carbapenems potent parenteral antibiotics, with ultra-broad spectrum activity encompasses multi-drug resistant Gram-negative bacteria. Clinical trial data supports clinical effectiveness these agents patients difficult treat pathogens.

参考文章(78)
Angelika Böhme, L. Bergmann, D. Hoelzer, G. Just-Nübling, P. M. Shah, W. Stille, A randomized study of imipenem compared to cefotaxime plus piperacillin as initial therapy of infections in granulocytopenic patients. Infection. ,vol. 23, pp. 349- 355 ,(1995) , 10.1007/BF01713564
JORDI RELLO, MARCIO SA-BORGES, HUMBERTO CORREA, SANTIAGO-RAMON LEAL, JORGE BARAIBAR, Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. American Journal of Respiratory and Critical Care Medicine. ,vol. 160, pp. 608- 613 ,(1999) , 10.1164/AJRCCM.160.2.9812034
Michael A Pfaller, Ronald N Jones, Douglas J Biedenbach, MYSTIC Program Study Group, Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA). Diagnostic Microbiology and Infectious Disease. ,vol. 41, pp. 177- 182 ,(2001) , 10.1016/S0732-8893(01)00319-4
Jose Garnacho-Montero, Jose Luis Garcia-Garmendia, Ana Barrero-Almodovar, Francisco J. Jimenez-Jimenez, Carmen Perez-Paredes, Carlos Ortiz-Leyba, Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Critical Care Medicine. ,vol. 31, pp. 2742- 2751 ,(2003) , 10.1097/01.CCM.0000098031.24329.10
Miriam Hurst, Harriet M. Lamb, Meropenem: a review of its use in patients in intensive care. Drugs. ,vol. 59, pp. 653- 680 ,(2000) , 10.2165/00003495-200059030-00016